CN108048325B - Method for removing barium, gallium and manganese ions in human excrement by using lithium-based halloysite - Google Patents
Method for removing barium, gallium and manganese ions in human excrement by using lithium-based halloysite Download PDFInfo
- Publication number
- CN108048325B CN108048325B CN201711214862.4A CN201711214862A CN108048325B CN 108048325 B CN108048325 B CN 108048325B CN 201711214862 A CN201711214862 A CN 201711214862A CN 108048325 B CN108048325 B CN 108048325B
- Authority
- CN
- China
- Prior art keywords
- lithium
- halloysite
- excrement
- gallium
- slurry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Abstract
The invention discloses a method for removing barium, gallium and manganese ions in human excrement by utilizing lithium-based halloysite. The invention can remove barium, gallium and manganese ions in human excrement by specific adsorption, so that the excrement donated by excrement donors with over-standard barium, gallium and manganese ions can reach the standard after treatment.
Description
Technical Field
The invention belongs to the technical field of human excrement bacterium transplanting, fermenting and detecting, and relates to a method for removing barium, gallium and manganese ions in human excrement by utilizing lithium-based halloysite.
Background
"Fecal transplantation" (FMT) refers to the transplantation of functional flora in the feces of healthy people into the gastrointestinal tract of patients to reconstruct new intestinal flora and realize the treatment of intestinal and parenteral diseases. Fecal transplantation has been used for the treatment and exploratory studies of various flora-related diseases such as clostridium difficile infection, inflammatory bowel disease, intractable constipation, metabolic disease, intestinal immunodeficiency, intestinal allergy and the like as an effective means for reconstructing intestinal flora, and is considered as a breakthrough medical progress in recent years.
The fecal bacteria feeding way is divided into an upper digestive tract, a middle digestive tract and a lower digestive tract. The upper digestive tract route mainly refers to oral fecal bacteria capsule; the middle digestive tract route comprises passing through a nasointestinal tube, a gastroscope forceps channel hole and a percutaneous endoscopic gastrostomy jejunum tube; the lower gastrointestinal route includes colonoscopy, enema, colostomy, and endoscopic intestinal catheterization (TET). The physician should select the most appropriate input route for the patient according to his condition and the characteristics of the various routes.
The state of the coprophilous fungi transplantation can be divided into three forms of freshness, freezing storage and fermentation. Since the safety of fecal bacteria transplantation is the primary consideration in clinical decision making, in order to isolate a high quality fecal flora without pathogens, the fecal donors are highly demanding, at least within 3-6 months no diarrhea occurs, no antibiotics have been used, and there must be no infectious diseases and gastrointestinal diseases, in addition, there are limitations including age, physiology, pathology, psychology, integrity, time, environment, etc.
As the fecal bacteria provided by qualified fecal donors can not meet the clinical requirements at all, the fecal bacteria with certain ions exceeding the standard is processed by the technology, so that the fecal bacteria meets the requirements of fecal bacteria transplantation, and the method has very important practical significance.
With the change of human living environment, the exceeding of barium, gallium and manganese ions in human excrement is more and more common, and when the barium, gallium and manganese ions in excrement of an excrement provider exceed the standard, the requirements of excrement bacterium transplantation are not met.
Disclosure of Invention
The invention aims to provide a method for removing barium, gallium and manganese ions in human excrement by using lithium-based halloysite.
The technical scheme adopted by the invention is as follows:
a method for preparing a fecal bacterial solution by removing barium, gallium and manganese ions in human feces by utilizing lithium halloysite,
1) adding a sterile NaCl solution into the excrement sample, adding lithium-based halloysite, and uniformly stirring to obtain excrement slurry;
2) primarily filtering the excrement slurry, taking filtrate, and stirring the filtrate at 1800-2200 rpm for 3-6 min every 0.8-1.2 h under the protection of carbon dioxide gas, nitrogen gas, helium gas, neon gas or argon gas for 4-7 h to obtain excrement and bacteria slurry;
3) filtering the fecal strain slurry to obtain filtrate to obtain crude fecal strain liquid; and centrifuging the crude fecal strain liquid, taking the precipitate, and suspending to obtain colorless and tasteless fecal strain liquid containing no barium, gallium and manganese ions.
Further, the preparation method of the lithium-based halloysite comprises the following steps: adding water and lithium metaphosphate into halloysite minerals, heating to 70-80 ℃, and adding Na2CO3(ii) a Stirring for 2.5-3.5 h, standing for 20-30 h, then centrifugally washing with deionized water, recovering solids, and drying to obtain the lithium-based halloysite.
Further, the halloysite mineral, lithium metaphosphate and Na2CO3And the dosage ratio of water is 80-120 g: 8-12 g: 18-22 g: 1L of the compound.
Furthermore, the cation exchange capacity of the obtained lithium halloysite is 30-50 mmol/100 g.
Further, in the step 1), the dosage ratio of the excrement sample, the NaCl solution and the lithium-based halloysite is 1 g: 3-7 mL: 1.5-3 g.
Further, the concentration of the NaCl solution is 0.85-0.95% w/v.
Further, in the step 1), the stirring speed is 1800-2200 rpm, and the time is 2-4 min.
Further, in step 2), the specific operations of the primary filtering are as follows: and filtering the excrement slurry by using a filter screen with the aperture of 4.5-5.5 mm to remove large-particle substances.
Further, in step 3), the specific operation of filtering the fecal sewage sludge is as follows: filtering by a filter screen with the aperture of 1.5-2.5 mm, 0.8-1.2 mm, 0.4-0.6 mm and 0.2-0.3 mm in sequence.
Further, in the step 3), the rotation speed of the centrifugation is 5500-6500 rpm, and the time is 12-18 min.
The invention has the beneficial effects that:
at present, a method for removing barium ions, gallium ions and manganese ions in human excrement is not reported temporarily, and the method can remove the barium ions, the gallium ions and the manganese ions in the human excrement through specific adsorption, so that excrement donated by excrement donors with over-standard barium ions, gallium ions and manganese ions can reach the standard after treatment.
Detailed Description
A method for preparing a fecal bacterial solution by removing barium, gallium and manganese ions in human feces by utilizing lithium halloysite,
1) adding a sterile NaCl solution into the excrement sample, adding lithium-based halloysite, and uniformly stirring to obtain excrement slurry;
2) primarily filtering the excrement slurry, taking filtrate, and stirring the filtrate at 1800-2200 rpm for 3-6 min every 0.8-1.2 h under the protection of carbon dioxide gas, nitrogen gas, helium gas, neon gas or argon gas for 4-7 h to obtain excrement and bacteria slurry;
3) filtering the fecal strain slurry to obtain filtrate to obtain crude fecal strain liquid; and centrifuging the crude fecal strain liquid, taking the precipitate, and suspending to obtain colorless and tasteless fecal strain liquid containing no barium, gallium and manganese ions.
Preferably, the preparation method of the lithium-based halloysite comprises the following steps: adding water and lithium metaphosphate into halloysite minerals, heating to 70-80 ℃, and adding Na2CO3(ii) a Stirring for 2.5-3.5 h, standing for 20-30 h, then centrifugally washing with deionized water, recovering solids, and drying to obtain the lithium-based halloysite.
Preferably, the halloysite mineral, lithium metaphosphate and Na2CO3And the dosage ratio of water is 80-120 g: 8-12 g: 18-22 g: 1L of the compound.
Preferably, the drying temperature is 100-110 ℃, and the drying time is 45-55 h.
Preferably, the cation exchange capacity of the obtained lithium halloysite is 30-50 mmol/100 g.
Preferably, in the step 1), the dosage ratio of the excrement sample to the NaCl solution to the lithium-based halloysite is 1 g: 3-7 mL: 1.5-3 g.
Preferably, the concentration of the NaCl solution is 0.85-0.95% w/v.
Preferably, in the step 1), the stirring speed is 1800-2200 rpm, and the time is 2-4 min.
Preferably, in step 2), the preliminary filtration specifically comprises: and filtering the excrement slurry by using a filter screen with the aperture of 4.5-5.5 mm to remove large-particle substances.
Preferably, in step 3), the specific operation of filtering the fecal sewage sludge is as follows: filtering by a filter screen with the aperture of 1.5-2.5 mm, 0.8-1.2 mm, 0.4-0.6 mm and 0.2-0.3 mm in sequence.
Preferably, in the step 3), the rotation speed of the centrifugation is 5500-6500 rpm, and the time is 12-18 min.
Preferably, in step 3), the liquid used for resuspension is a sterile 0.85% -0.95% w/v NaCl solution.
The present invention will be further described with reference to the following examples.
The embodiments of the present invention are described below with reference to specific embodiments, and other advantages and effects of the present invention will be easily understood by those skilled in the art from the disclosure of the present specification. The invention is capable of other and different embodiments and of being practiced or of being carried out in various ways, and its several details are capable of modification in various respects, all without departing from the spirit and scope of the present invention.
It should be understood that the processing equipment or devices not specifically mentioned in the following examples are conventional in the art; all pressure values and ranges refer to absolute pressures.
Furthermore, it is to be understood that one or more method steps mentioned in the present invention does not exclude that other method steps may also be present before or after the combined steps or that other method steps may also be inserted between these explicitly mentioned steps, unless otherwise indicated; it is also to be understood that a combined connection between one or more devices/apparatus as referred to in the present application does not exclude that further devices/apparatus may be present before or after the combined device/apparatus or that further devices/apparatus may be interposed between two devices/apparatus explicitly referred to, unless otherwise indicated. Moreover, unless otherwise indicated, the numbering of the various method steps is merely a convenient tool for identifying the various method steps, and is not intended to limit the order in which the method steps are arranged or the scope of the invention in which the invention may be practiced, and changes or modifications in the relative relationship may be made without substantially changing the technical content.
Wherein the concentration of barium, gallium, manganese ions in fecal bacteria is tested by inductively coupled plasma spectrometer (ICP, Optima 2000DV, USA) (test methods references Xiaoang Cai, Guang-Jian Dai, Shao-Zao Tan, Yu Ouyang, You-Sheng Ouyang, Qi-Shan Shi. synergistic interaction information and ceramic ions loaded. alpha. -zirconium phosphate. materials letters.2012,67(1): 199-) 201.).
Example 1 method for preparing fecal bacterial liquid by removing barium, gallium and manganese ions in human feces with lithium-based halloysite
(1) Preparation of lithium halloysite: adding 100g halloysite mineral into 1L water, adding 10g lithium metaphosphate, heating to 75 deg.C, adding 20g Na2CO3(ii) a Stirring for 3h at an electromagnetic speed of 60rpm, standing for 24h, centrifugally washing for 4 times by using deionized water, removing insoluble substances at the bottom, and recovering solids; drying at 105 ℃ for 48h to obtain the lithium halloysite; the resulting lithium-based halloysite had a Cation Exchange Capacity (CEC) of 35mmol/100 g.
(2) Taking 100 +/-0.1 g of lithium-based halloysite (the particle size is 0.5-2.0 mm), adding 100mL of sterile 0.9% NaCl solution, stirring at 500r/min for 5min, and filtering out water by a stainless steel filter screen of 0.25mm to obtain lithium-based halloysite slurry for later use.
(3) Placing 50 +/-1 g of donor fresh excrement in a stirrer, adding 250mL of sterile 0.9% NaCl solution, adding the prepared lithium-based halloysite slurry (the particle size is 0.5-2.0 mm), and homogenizing at 2000r/min for 3min to obtain excrement slurry;
(4) filtering the excrement slurry by a stainless steel filter screen with the thickness of 5.0mm to remove large-particle substances in the excrement slurry, and obtaining excrement slurry after primary filtration;
(5) transporting the primarily filtered excrement slurry ice to a laboratory and processing the excrement slurry ice within 2 hours after collection;
(6) transferring the primarily filtered excrement slurry into a nitrogen bioengineering kitchen, introducing carbon dioxide gas, and stirring for 5min at a speed of 2000r/min in a homogenizer every 1h, and obtaining excrement and bacteria slurry after 6 h;
(7) filtering the fecal strain slurry by stainless steel filter screens with diameters of 2.0mm, 1.0mm, 0.5mm and 0.25mm step by step to remove lithium halloysite adsorbing barium, gallium and manganese ions, lithium carbonate, unabsorbed food residues and small particle substances to obtain a crude fecal strain liquid;
(8) the crude fecal bacterial liquid is centrifuged at 6000r/min for 15min, and the fecal bacterial pellet is resuspended in 250mL of 0.9% NaCl solution to obtain 250mL of nearly colorless and odorless fecal bacterial liquid.
The total content of barium, gallium and manganese ions in the obtained fecal strain liquid is determined to be zero (the total content of barium, gallium and manganese ions can not be detected by an instrument and is less than 4ppb), and the content of sodium ions is 155 mmol/L.
Blank control group: the procedure was the same as that of the above-mentioned steps (1) to (8) except that feces and lithium-based halloysite were not added to obtain 250mL of a nearly colorless and odorless liquid, and the total content of barium, gallium and manganese ions in the liquid was determined to be zero (the total content of barium, gallium and manganese ions was less than 4ppb, which could not be detected by an instrument), and the content of sodium ions was determined to be zero (see Table 1).
Comparative group 1 (with stool and no halloysite): the operation steps are the same as the steps (1) to (8) in the embodiment, except that no lithium-based halloysite is added, 250mL of nearly colorless and odorless liquid is obtained, the contents of barium, gallium and manganese ions in the liquid are respectively measured to be 4.9mmol/L, 1.3mmol/L and 1.1mmol/L, the total content of barium, gallium and manganese ions is 7.3mmol/L, and the content of sodium ions is 153.9 mmol/L.
Comparative group 2 (with feces and halloysite): the procedure was as in the above-mentioned steps (1) to (8) of this example except that halloysite was added without addition of lithium-based halloysite to obtain 250mL of a nearly colorless and odorless liquid, and the contents of barium, gallium and manganese ions in the liquid were measured to be 4.3mmol/L, 0.8mmol/L and 0.8mmol/L, respectively, and the total content of barium, gallium and manganese ions was measured to be 5.9mmol/L and the content of sodium ions was measured to be 153.9mmol/L (see Table 1).
TABLE 1 results of the determination of the ion content in the different treatment groups
Note:ammol/L, mmol/L;
bN/A, which cannot be detected by instruments, and the content is less than 4ppb (ppb: mu g/L).
As can be seen from Table 1, the donor fresh feces treated by lithium-based halloysite and having excessive barium ions, gallium ions and manganese ions do not contain any barium ions, gallium ions and manganese ions, so that the feces donated by feces donors having excessive barium ions, gallium ions and manganese ions can reach the standard after treatment, and the content of sodium ions is basically kept unchanged.
Embodiment 2 method for preparing fecal bacterial liquid by removing barium, gallium and manganese ions in human feces through lithium-based halloysite
(1) Preparation of lithium halloysite: adding 120g halloysite mineral (commercial product with particle size of 0.5-2.0 mm) into 1L water, adding 8g lithium metaphosphate, heating to 80 deg.C, adding 22g Na2CO3(ii) a Stirring at an electromagnetic speed of 60rpm for 3.5h, standing for 20h, centrifuging and washing with deionized water for 4 times, removing insoluble substances at the bottom, and recovering solids; drying for 45h at 100 ℃ to obtain the lithium halloysite; the resulting lithium-based halloysite had a Cation Exchange Capacity (CEC) of 50mmol/100 g.
(2) Placing 50 +/-1 g of donor fresh excrement in a stirrer, adding 150mL of sterile 0.95% NaCl solution, adding 75g of lithium halloysite (the particle size is 0.5-2.0 mm), and homogenizing at 2200r/min for 4min to obtain excrement slurry;
(3) filtering the excrement slurry by a stainless steel filter screen with the thickness of 5.0mm to remove large-particle substances in the excrement slurry, and obtaining excrement slurry after primary filtration;
(4) transporting the primarily filtered excrement slurry ice to a laboratory and processing the excrement slurry ice within 2 hours after collection;
(5) transferring the primarily filtered excrement slurry into a nitrogen bioengineering kitchen, introducing nitrogen gas, and stirring for 5min at a speed of 2000r/min in a homogenizer every 1.2h, and obtaining excrement and bacteria slurry after 4 h;
(6) filtering the fecal strain slurry by stainless steel filter screens with diameters of 2.0mm, 1.0mm, 0.5mm and 0.25mm step by step to remove lithium halloysite adsorbing barium, gallium and manganese ions, lithium carbonate, unabsorbed food residues and small particle substances to obtain a crude fecal strain liquid;
(7) centrifuging the crude fecal strain liquid at 6500r/min for 18min, and suspending the fecal strain precipitate in 250mL of 0.9% NaCl solution to obtain 250mL of nearly colorless and odorless fecal strain liquid containing no barium, gallium and manganese ions.
Embodiment 3 method for preparing fecal bacterial liquid by removing barium, gallium and manganese ions in human feces through lithium-based halloysite
(1) Preparation of lithium halloysite: 80g of halloysite mineral (commercial product, granulate)Diameter of 0.5-2.0 mm) into 1L of water, adding 12g of lithium metaphosphate, heating to 70 deg.C, adding 18g of Na2CO3(ii) a Stirring for 2.5h at an electromagnetic speed of 60rpm, standing for 30h, centrifuging and washing for 4 times by using deionized water, removing insoluble substances at the bottom, and recovering solids; drying at 110 ℃ for 55h to obtain lithium halloysite; the resulting lithium-based halloysite had a Cation Exchange Capacity (CEC) of 30mmol/100 g.
(2) Placing 50 +/-1 g of fresh donor excrement in a stirrer, adding 350mL of sterile 0.85% NaCl solution, adding 130g of lithium-based halloysite (the particle size is 0.5-2.0 mm), and homogenizing at 2200r/min for 4min to obtain excrement slurry;
(3) filtering the excrement slurry by a stainless steel filter screen with the thickness of 5.0mm to remove large-particle substances in the excrement slurry, and obtaining excrement slurry after primary filtration;
(4) transporting the primarily filtered excrement slurry ice to a laboratory and processing the excrement slurry ice within 2 hours after collection;
(5) transferring the primarily filtered excrement slurry into a nitrogen bioengineering kitchen, introducing nitrogen gas, and stirring for 5min at a speed of 2000r/min in a homogenizer every 1.2h, and obtaining excrement and bacteria slurry after 4 h;
(6) filtering the fecal strain slurry by stainless steel filter screens with diameters of 2.0mm, 1.0mm, 0.5mm and 0.25mm step by step to remove lithium halloysite adsorbing barium, gallium and manganese ions, lithium carbonate, unabsorbed food residues and small particle substances to obtain a crude fecal strain liquid;
(7) centrifuging the crude fecal strain solution at 6500r/min for 12min, and suspending the fecal strain precipitate in 250mL of 0.9% NaCl solution to obtain 250mL of nearly colorless and odorless fecal strain solution free of barium, gallium and manganese ions.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Claims (9)
1. A method for preparing a fecal strain solution by removing barium, gallium and manganese ions in human feces by utilizing lithium-based halloysite is characterized by comprising the following steps:
1) adding a sterile NaCl solution into the excrement sample, adding lithium-based halloysite, and uniformly stirring to obtain excrement slurry;
2) primarily filtering the excrement slurry, taking filtrate, and stirring the filtrate at 1800-2200 rpm for 3-6 min every 0.8-1.2 h under the protection of carbon dioxide gas, nitrogen gas, helium gas, neon gas or argon gas for 4-7 h to obtain excrement and bacteria slurry;
3) filtering the fecal strain slurry to obtain filtrate to obtain crude fecal strain liquid; centrifuging the crude fecal strain liquid, taking the precipitate, and re-suspending to obtain colorless and odorless fecal strain liquid containing no barium, gallium and manganese ions;
the preparation method of the lithium-based halloysite comprises the following steps: adding water and lithium metaphosphate into halloysite minerals, heating to 70-80 ℃, and adding Na2CO3(ii) a Stirring for 2.5-3.5 h, standing for 20-30 h, then centrifugally washing with deionized water, recovering solids, and drying to obtain the lithium-based halloysite.
2. The method of claim 1, wherein the halloysite mineral, lithium metaphosphate, Na2CO3And the dosage ratio of water is 80-120 g: 8-12 g: 18-22 g: 1L of the compound.
3. The method of claim 1, wherein the resulting lithium-based halloysite has a cation exchange capacity of 30 to 50mmol/100 g.
4. The method according to claim 1, wherein in the step 1), the dosage ratio of the excrement sample, the NaCl solution and the lithium-based halloysite is 1 g: 3-7 mL: 1.5-3 g.
5. The method according to claim 1, wherein the concentration of the NaCl solution is between 0.85% and 0.95% w/v.
6. The method according to claim 1, wherein in the step 1), the stirring speed is 1800-2200 rpm and the time is 2-4 min.
7. The method according to claim 1, wherein in step 2), the preliminary filtering is performed by: and filtering the excrement slurry by using a filter screen with the aperture of 4.5-5.5 mm to remove large-particle substances.
8. The method according to claim 1, wherein in the step 3), the specific operation of the fecal sewage sludge filtration is as follows: filtering by a filter screen with the aperture of 1.5-2.5 mm, 0.8-1.2 mm, 0.4-0.6 mm and 0.2-0.3 mm in sequence.
9. The method according to claim 1, wherein in the step 3), the rotation speed of the centrifugation is 5500-6500 rpm, and the time is 12-18 min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711214862.4A CN108048325B (en) | 2017-11-28 | 2017-11-28 | Method for removing barium, gallium and manganese ions in human excrement by using lithium-based halloysite |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711214862.4A CN108048325B (en) | 2017-11-28 | 2017-11-28 | Method for removing barium, gallium and manganese ions in human excrement by using lithium-based halloysite |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108048325A CN108048325A (en) | 2018-05-18 |
| CN108048325B true CN108048325B (en) | 2021-04-13 |
Family
ID=62120800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711214862.4A Active CN108048325B (en) | 2017-11-28 | 2017-11-28 | Method for removing barium, gallium and manganese ions in human excrement by using lithium-based halloysite |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108048325B (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1211468A (en) * | 1997-07-22 | 1999-03-24 | 策卡有限公司 | Improved binding type zeolite adsorbent, its producing process and its application in non-deep-cooling separation of industrial gas |
| CN101690888A (en) * | 2009-10-16 | 2010-04-07 | 清华大学 | Method for preparing chemical absorbent with porous mineral |
| CN103601203A (en) * | 2013-10-25 | 2014-02-26 | 浙江理工大学 | Halloysite nanotube purification method |
| CN104922158A (en) * | 2015-06-05 | 2015-09-23 | 中国人民解放军第三军医大学第三附属医院 | Fecal microbiota capsule, as well as preparation method and application thereof |
| CN105664848A (en) * | 2016-01-14 | 2016-06-15 | 江苏大学 | Preparation method of lignin hierarchical porous carbon material with endellite as template |
| CN106946485A (en) * | 2017-03-24 | 2017-07-14 | 吉林大学 | A kind of lithium is modified illite cement intensifier and preparation method |
-
2017
- 2017-11-28 CN CN201711214862.4A patent/CN108048325B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1211468A (en) * | 1997-07-22 | 1999-03-24 | 策卡有限公司 | Improved binding type zeolite adsorbent, its producing process and its application in non-deep-cooling separation of industrial gas |
| CN101690888A (en) * | 2009-10-16 | 2010-04-07 | 清华大学 | Method for preparing chemical absorbent with porous mineral |
| CN103601203A (en) * | 2013-10-25 | 2014-02-26 | 浙江理工大学 | Halloysite nanotube purification method |
| CN104922158A (en) * | 2015-06-05 | 2015-09-23 | 中国人民解放军第三军医大学第三附属医院 | Fecal microbiota capsule, as well as preparation method and application thereof |
| CN105664848A (en) * | 2016-01-14 | 2016-06-15 | 江苏大学 | Preparation method of lignin hierarchical porous carbon material with endellite as template |
| CN106946485A (en) * | 2017-03-24 | 2017-07-14 | 吉林大学 | A kind of lithium is modified illite cement intensifier and preparation method |
Non-Patent Citations (2)
| Title |
|---|
| Adsorption of a few heavy metals on natural and modified kaolinite and montmorillonite: A review;Krishna GopalBhattacharyya等;《Advances in Colloid and Interface Science》;20080831;第140卷(第2期);第114-131页 * |
| 埃洛石的结构特性、表面改性及应用研究进展;范利丹等;《材料导报A》;20060228;第30卷(第2期);第96-100页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108048325A (en) | 2018-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104922158B (en) | Caprophyl capsule and its preparation and application | |
| CA2986915C (en) | Microbiota restoration therapy (mrt) compositions and methods of manufacture | |
| CN112089736B (en) | Whole fungus capsule and preparation method and application thereof | |
| CN109355349B (en) | Ackermansoni specificity screening culture medium and preparation method and application thereof | |
| CN109609420B (en) | Helicobacter pylori-resistant probiotic composition and preparation method thereof | |
| WO2019241523A1 (en) | Microbiota restoration therapy (mrt) compositions and methods of manufacture | |
| CN108048325B (en) | Method for removing barium, gallium and manganese ions in human excrement by using lithium-based halloysite | |
| CN108085270B (en) | Method for preparing iron-free titanium bismuth ion-free fecal bacteria liquid | |
| CN107881109B (en) | Method for preparing fecal strain liquid by removing copper, lead and zinc ions in human feces through lithium illite | |
| CN108085271B (en) | Method for removing mercury, thallium and arsenic ions in human excrement | |
| CN108152096B (en) | Method for removing tellurium, selenium and cobalt ions in human excrement by utilizing lithium-based chlorite | |
| CN107974410B (en) | Method for removing magnesium, calcium and aluminum ions in human excrement by using lithium-based vermiculite | |
| CN109394795A (en) | A kind of intestines bacterium capsule preparation method thereof and intestines bacterium capsule | |
| Rivas et al. | Approach to kidney stones associated with ureteropelvic junction obstruction during laparoscopic pyeloplasty | |
| CN110938563B (en) | Lactobacillus BJ-REBORN001 and application thereof in preparation of helicobacter pylori inhibiting fermentation broth | |
| CN107034159B (en) | Pathogenic bacteria antagonist and application thereof | |
| CN109757730B (en) | Composition with functions of reducing blood fat, blood pressure and blood sugar and preparation method thereof | |
| CN109846044B (en) | Probiotic composition with functions of improving memory and enhancing immunity and preparation method thereof | |
| CN111888381A (en) | Intestinal microorganism transplanting process | |
| CN111534466B (en) | Method and reagent for processing human fecal intestinal flora sample | |
| CN111548964A (en) | Lactobacillus casei and application thereof in preventing and treating nephritis | |
| CN111084783A (en) | Fish body surface polysaccharide and application of fish body surface digestive polysaccharide | |
| CN112656766A (en) | Fecal fungus freeze-drying and capsule preparation process for fecal fungus transplantation treatment | |
| CN116694492A (en) | Helicobacter pylori enrichment medium, preparation method thereof and helicobacter pylori enrichment method | |
| CN114042090A (en) | Intestinal flora capsule and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |